Dynavax Investor Alert: Kahn Swick & Foti Investigates Proposed Sale Adequacy - DVAX

Tuesday, Dec 30, 2025 10:21 am ET1min read
DVAX--

Dynavax Technologies Corporation (DVAX) is being investigated by Kahn Swick & Foti, LLC regarding the proposed sale to Sanofi. The law firm is seeking to determine if the proposed transaction undervalues the company. Shareholders who believe the consideration is inadequate can contact Lewis S. Kahn at 855-768-1857 or visit ksfcounsel.com. The transaction is structured as a tender offer, making time of the essence.

Dynavax Investor Alert: Kahn Swick & Foti Investigates Proposed Sale Adequacy - DVAX

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet